Document:

‌​

RESTRICTED STOCK AGREEMENT
NABORS INDUSTRIES, INC.
​
This Restricted Stock Grant (“Restricted Stock Grant”) between Nabors Industries, Inc. (“NII”), acting on behalf of Nabors Industries Ltd. (“NIL” or the “Company”), and William Restrepo  (“Grantee”), an Eligible Recipient, contains the terms and conditions under which the Compensation Committee of the Board (the “Committee”), has awarded to Grantee, effective as of January 1, 2022 (the “Date of Grant”) and pursuant to the Amended and Restated Nabors Industries Ltd. 2016 Stock Plan (“2016 Plan”), certain restricted Common Shares of the Company to incentivize Grantee to contribute to the success of the Company.  The applicable terms of the 2016 Plan are incorporated in this Restricted Stock Grant by reference. Capitalized terms used but not defined herein shall have the meanings set forth in the 2016 Plan.
​
​
RESTRICTED STOCK GRANT
​
In accordance with the terms of the 2016 Plan, the Committee has made this Restricted Stock Grant and concurrently has issued or transferred to Grantee Common Shares upon the following terms and conditions:
​
SECTION 1.  Number of Shares.  The number of shares awarded under this Restricted Stock Grant is [  ] (the “Award”).
​
SECTION 2.  Rights of Grantee as Shareholder.  Grantee, as the owner of the Common Shares issued or transferred pursuant to this Restricted Stock Grant, is entitled to all the rights of a shareholder of NIL, including the right to vote, the right to receive dividends payable either in stock or in cash, and the right to receive shares in any recapitalization of the Company, subject, however, to the restrictions stated in this Restricted Stock Grant.  If Grantee receives any additional shares by reason of being the holder of the Common Shares issued or transferred under this Restricted Stock Grant or of the additional shares previously distributed to Grantee, all of the additional shares shall be subject to the provisions of this Restricted Stock Grant.  Initially, the Common Shares will be held in an account maintained with the processor under the 2016 Plan (the “Account”).  At the discretion of NIL, NIL may provide Grantee with a certificate for the shares, which would bear a legend as described in Section 5.
​
SECTION 3.  Restriction Period.  The period of restriction (“Restriction Period”) for the Common Shares issued under this Restricted Stock Grant (the “Restricted Shares”) shall commence on the Date of Grant and shall lapse, if at all, as follows:
​
 (a) The Committee, in its sole discretion, has established target Performance Goals based on the Company’s Total Shareholder Return (“TSR Targets”), which will be measured over a three-fiscal-year performance cycle commencing on January 1, 2022 and ending on December 31, 2024 (such period, the “Performance Cycle”). Total Shareholder Return (“TSR”) is the percentage increase in the value of shares over the Performance Cycle, based on the average closing share price for the thirty (30) consecutive business days prior to the start of the Performance Cycle and the average closing share price for the last thirty (30) consecutive business days in the 

US 7612676

Performance Cycle.  The increase is calculated as the sum of (i) the change in share price and (ii) the value of dividends declared during the Performance Cycle, assuming such dividends are reinvested in additional shares as of the date they are declared. The Company’s TSR will be compared to the TSR of a peer group (the “Peer Group”) comprised of those companies set forth on Exhibit A attached hereto and made a part hereof, to determine relative TSR (“RTSR”). The Peer Group may be adjusted by the Committee from time to time during or at the conclusion of the Performance Cycle, in its sole discretion after consultation with Grantee, in the event any of the companies in the Peer Group cease to be publicly traded or in response to a merger, consolidation or divestiture activity amongst companies, available public reporting or other events actually or potentially affecting the composition of the Peer Group.  
(b) Restrictions will lapse based upon TSR relative to the Peer Group, pursuant to the schedule on Exhibit B; provided, however, that if the Company’s TSR for the Performance Cycle is negative, then the restrictions shall not lapse as to more than 50% of the Award.  The Committee shall have sole discretion to determine which RTSR level has been achieved (if any) and whether the restrictions shall lapse on any or all of the Restricted Shares. The Committee’s determinations pursuant to the exercise of discretion with respect to all matters described in this paragraph shall be final and binding on Grantee. The Committee shall make this determination not later than sixty (60) days following the end of the Performance Cycle or as soon as administratively practicable thereafter, with any lapses to occur as of the date of determination (the “TSR Vesting Date”).
(c)  If, as of the TSR Vesting Date, the Committee determines that restrictions shall lapse for less than one hundred percent (100%) of the Restricted Shares, neither Grantee nor any of his heirs, beneficiaries, executors, administrators or other personal representatives shall have any further rights whatsoever in or with respect to any of the remaining Restricted Shares and all such shares shall be forfeited to NIL without consideration.
(d) In the event of a Change in Control of NIL (as defined in the Executive Employment Agreement by and between NIL, NII and Grantee effective as of January 2, 2020, as amended from time to time (the “Employment Agreement”)), one hundred percent (100%) of the unvested Restricted Shares held by Grantee shall become vested immediately. 
(e) In the event of termination of Grantee’s employment by reason of Disability (as defined in the Employment Agreement) or death, fifty percent (50%) of the unvested Restricted Shares held by Grantee or his designated beneficiary (as applicable) shall become vested on the TSR Vesting Date.  
(f) In the event of termination of Grantee’s employment either by Grantee for Constructive Termination Without Cause, or by the Company Without Cause (each as defined in the Employment Agreement), fifty percent (50%) of the unvested Restricted Shares held by Grantee shall become vested on the TSR Vesting Date.
(g) In the event of termination of Grantee’s employment due to a qualifying retirement pursuant to Section 5.5 of the Employment Agreement, one hundred percent (100%) of the unvested Restricted Shares held by Grantee shall become vested on the TSR Vesting Date.
(h) Anything herein notwithstanding, in the event of the termination of Grantee’s employment by the Company for Cause or by the written voluntary resignation of Grantee (each as contemplated in the Employment Agreement), Grantee shall forfeit any Restricted Shares to the 

2
​

extent the restrictions on those shares have not lapsed as of the date the Executive’s employment is terminated. 
 (i) Upon the release of the Restricted Shares from the restrictions, the Restricted Shares held by Grantee or his designated beneficiary (as applicable) shall be distributed to Grantee or his designated beneficiary (as applicable). No fractional Common Shares will be issued. If the calculation of the number of Common Shares to be issued results in fractional shares, then the number of Common Shares will be rounded up to the nearest whole Common Share.
​
SECTION 4.  Terms and Conditions.  The Award is subject to the following terms and conditions: 
​
(a)The Award made to Grantee shall be for the benefit of Grantee, his heirs, devisees, legatees or assigns at any time.
​
(b)Except as otherwise expressly provided herein, this Restricted Stock Grant is subject to, and NII and Grantee agree to be bound by, all the terms and conditions of the 2016 Plan, as the same may have been amended from time to time in accordance with its terms.  Pursuant to the 2016 Plan, the Board or the Committee is vested with conclusive authority to interpret and construe the 2016 Plan and this Restricted Stock Grant, and is authorized to adopt rules and regulations for carrying out the 2016 Plan.  Further, the parties reserve the right to clarify or amend this Restricted Stock Grant on mutually acceptable terms in any manner which would have been permitted under the 2016 Plan as of the Date of Grant.
​
SECTION 5.  Legend on Certificates.  Any certificate evidencing ownership of Common Shares issued or transferred pursuant to this Restricted Stock Grant that is delivered during the Restriction Period shall bear the following legend on the back side of the certificate:
​
These shares have been issued or transferred subject to a Restricted Stock Grant and are subject to certain restrictions as more particularly set forth in a Restricted Stock Grant Agreement, a copy of which is on file with  Nabors Corporate Services, Inc.
​
At the discretion of NIL, NIL may hold the Common Shares issued or transferred pursuant to this Restricted Stock Grant in an Account as described in Section 2, otherwise hold them in escrow during the Restriction Period, or issue a certificate to Grantee bearing the legend set forth above.
​
SECTION 6.  Section 83(b) Election.  If Grantee makes an election pursuant to Section 83(b) of the Internal Revenue Code, Grantee shall promptly (but in no event after thirty (30) days from the Date of Grant) file a copy of such election with NIL, and cash payment for taxes shall be made at the time of such election.
​
SECTION 7.  Withholding Tax.  Before NIL removes restrictions on transfer from the Account or delivers a certificate for Common Shares issued or transferred pursuant to this Restricted Stock Grant that bears no legend or otherwise delivering shares free from restriction, Grantee shall be required to pay to NIL or to NII the amount of federal, state or local taxes, if any, required by law to be withheld (“Withholding Obligation”).  Subject to any Company policy in effect from time to 

3
​

time, NIL will withhold the number of shares required to satisfy any Withholding Obligation, and provide to Grantee a net balance of shares (“Net Shares”) unless NIL receives notice not less than five (5) days before any Withholding Obligation arises that Grantee intends to deliver funds necessary to satisfy the Withholding Obligation in such manner as NIL may establish or permit.  Notwithstanding any such notice, if Grantee has not delivered funds within fifteen (15) days after the Withholding Obligation arises, NIL may elect to deliver Net Shares.
​
SECTION 8.  Notices and Payments.  Any notice to be given by Grantee under this Restricted Stock Grant shall be in writing and shall be deemed to have been given only upon receipt by the Stock Plan Administrator of Nabors Corporate Services, Inc. at the offices of Nabors Corporate Services, Inc. in Houston, Texas, or at such address as may be communicated in writing to Grantee from time to time.  Any notice or communication by NIL or NII to Grantee under this Restricted Stock Grant shall be in writing and shall be deemed to have been given if sent to Grantee at the address listed in the records of NIL or at such address as specified in writing to NIL by Grantee.
​
SECTION 9.  Waiver.  The waiver by NIL of any provision of this Restricted Stock Grant shall not operate as, or be construed to be, a waiver of the same or any other provision of this Restricted Stock Grant at any subsequent time for any other purpose.
​
SECTION 10.  Governing Law & Severability.  The Plan and all rights and obligations thereunder shall be construed in accordance with and governed by the laws of the State of Delaware.  If any provision of this Restricted Stock Grant should be held invalid, the remainder of this Restricted Stock Grant shall be enforced to the greatest extent permitted by applicable law, it being the intent of the parties that invalid or unenforceable provisions are severable. 
​
SECTION 11.  Insider Trading/Market Abuse Laws. Grantee acknowledges that Grantee may be subject to insider trading restrictions and/or market abuse laws in applicable jurisdictions, including the United States and Grantee’s country (if different), which may affect Grantee’s ability to acquire or sell Common Shares or ability to otherwise receive Common Shares pursuant to an award under the Plan during such times as Grantee is considered to have “material non-public information” or other “inside information” regarding the Company or any of its affiliates. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. Grantee acknowledges that it is Grantee’s responsibility to be informed of and compliant with such regulations, and should consult Grantee’s personal advisor regarding such matters.
​
SECTION 12.  Entire Agreement.  This Restricted Stock Grant, together with the Plan, contains the entire agreement between the parties with respect to the subject matter and supersedes any and all prior understandings, agreements or correspondence between the parties; provided, however, that the terms of this Restricted Stock Grant shall not modify and shall be subject to the terms and conditions of any employment, consulting and/or severance agreement between the Company (or one of its affiliates) and Grantee in effect as of the date a determination is to be made under this Restricted Stock Grant.

4
​

IN WITNESS WHEREOF, the parties hereto have duly executed this Restricted Stock Grant as of the day and year first written above.  
​
NABORS INDUSTRIES, INC.
By:________________________
​
​
NABORS INDUSTRIES LTD.
By:________________________
​
​
GRANTEE
​
​ ​​ ​​ ​​ ​​ ​​
WILLIAM RESTREPO

5
​

Exhibit A
​
The 2022 Performance Peer Group shall be as follows:
​
	
●
Baker Hughes Company

	
●
Patterson-UTI Energy, Inc.

	
●
TechnipFMC plc

	
●
Schlumberger Limited

	
●
Halliburton Company

	
●
Transocean Ltd.

	
●
Helmerich & Payne, Inc.

	
●
Weatherford International plc

	
●
National-Oilwell Varco, Inc.

●
Flowserve Corporation

●
Valaris plc

	
●
Expro Group Holdings N.V.

●
Precision Drilling Corporation

●
Noble Corporation plc

​
​
​
​
​
​

6
​

Exhibit B
​
​
​
​
​
	​
RTSR RANK
	PERCENTAGE OF
SHARES
EARNED

	1, 2 or 3
	100%

	4 or 5
	75%

	6 or 7
	60%

	8 or 9
	50%

	10 or 11
	40%

	12 or 13
	25%

	14 or 15
	0%

​

7
​EX-10.1

 Exhibit 10.1 

FIRST AMENDMENT 
 TO THE

 EMPLOYMENT AGREEMENT BETWEEN 

LYRA THERAPEUTICS, INC. AND MARIA PALASIS 

This Amendment (the “Amendment”) to that certain Employment Agreement between Lyra Therapeutics, Inc., a Delaware corporation
(together with any successor thereto, the “Company”), and Maria Palasis (the “Executive”) dated as of April 27, 2020 (the “Employment Agreement”) is made as of this 16th day of February, 2022
(the “Amendment Date”), by and among the Company and the Executive. Except as set forth in this Amendment, capitalized terms used but not defined herein shall have the meanings ascribed to them in the Employment Agreement.

 WITNESSETH 
 WHEREAS,
the Company anticipates entering into an employment agreement with Harlan Waksal (the “Executive Chair Agreement”), pursuant to which Mr. Waksal will serve as the Executive Chair of the Company; and 

WHEREAS, subject to the execution of the Executive Chair Agreement (the “Agreement Execution”), the Company and the Executive
desire to amend the terms of the Employment Agreement as set forth herein; 
 NOW, THEREFORE, for good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the Executive and the Company (collectively the “Parties”) hereby agree, subject to and effective upon the Agreement Execution, to the following: 

1. Section 2 of the Employment Agreement is hereby amended to add a new subsection (g) as follows: 

(g) Transaction Bonus. In connection with a Change in Control in which the Market Capitalization of the Company equals
or exceeds $750 million, Executive shall be entitled to a cash bonus in the amount of 1.0% of the Market Capitalization (the “Transaction Bonus”). The Transaction Bonus shall be payable within thirty (30) days after the
completion of the Change in Control transaction, subject to Executive’s continued employment with the Company through the completion of the Change in Control transaction and execution, within thirty (30) days after the completion of the
Change in Control transaction, of a release of claims in favor of the Company materially consistent with the terms of the release attached as Exhibit B to this Agreement. 

2. Section 4(b) of the Employment Agreement is hereby amended to add a new subclause (iv) as follows: 

(iv) any vested and exercisable options held by Executive as of the Date of Termination, will remain outstanding and
exercisable for fifteen (15) months from the Date of Termination (provided that (a) in no event will any such option remain outstanding past the final expiration date set forth in the applicable option award agreement (b) all such
options will in all events remain subject to earlier termination in connection with a corporate transaction or event in accordance with the applicable option award agreement and the 2020 Incentive Award Plan, any equity plan subsequently adopted by
the Company or any successor plan, as applicable). 
 3. Section 4(c) of the Employment Agreement is hereby amended to replace the lead-in language in its entirety as follows: 

 In lieu of the payments and benefits set forth in Section 4(b), in
the event Executive’s employment terminates without Cause pursuant to Section 3(a)(iv), or due to Executive’s resignation with Good Reason pursuant to Section 3(a)(v), in either case,
within three (3) months prior or twelve (12) months following the date of a Change in Control, subject to Executive signing on or before the twenty-first (21st) day following Executive’s Separation from Service or in the event that
such Separation from Service is “in connection with an exit incentive or other employment termination program” (as such phrase is defined in the Age Discrimination in Employment Act of 1967, as amended) on or before the forty-fifth (45th)
day following Executive’s Separation from Service, and not revoking, the Release, and Executive’s continued compliance with Section 5, Executive shall receive, in addition to the payments and benefits set forth in
Section 3(c), the following: 
 4. Section 4(c) of the Employment Agreement is hereby amended to add a new
subclauses (v) and (vi) as follows: 
 (v) the benefits set forth in Section 4(b)(iv). 

(vi) The Transaction Bonus, provided that the conditions for issuance of the Transaction Bonus are otherwise satisfied in
accordance with Section 2(g). 
 5. Section 7 of the Employment Agreement is hereby amended to add a new subsection (g) as
follows: 
 (g) Market Capitalization. “Market Capitalization” shall mean an amount equal to the product of
(i) the cash price per share of the Company’s common stock (a “Share”) paid by an acquiror in connection with a Change in Control, or, if the consideration in the Change in Control transaction is payable in a form other
than a fixed amount of cash per Share, the closing price per Share on the last trading day preceding the closing date of the Change in Control, and (ii) the number of Shares outstanding as of immediately prior to the Change in Control. 

6. Waiver of Good Reason. Executive expressly agrees and acknowledges that none of the Agreement Execution, the hiring of
Mr. Waksal as the Executive Chair, the execution of this Amendment or any matters ancillary thereto or the implementation thereof shall constitute Good Reason for purposes of the Employment Agreement. 

7. No Other Amendment. Except as expressly set forth in this Amendment, the Employment Agreement shall remain unchanged and shall
continue in full force and effect according to its terms. In the event the Agreement Execution does not occur for any reason, this Amendment shall be null and void and of no force or effect. 

8. Acknowledgement. The Executive acknowledges and agrees that he has carefully read this Amendment in its entirety, fully understands
and agrees to its terms and provisions and intends and agrees that it be final and legally binding on the Executive and the Company. 
 9.
Governing Law; Counterparts. This Amendment shall be construed in accordance with the laws of the State of Delaware without reference to principles of conflicts of law and may be executed in several counterparts by the Parties. 

[Signature Page Follows] 

  
 2 

 IN WITNESS WHEREOF, the Executive has hereunto set the Executive’s hand and the Company
has caused this Amendment to be executed in its name on its behalf, all as of the Amendment Date. 
  

			
	LYRA THERAPEUTICS, INC.
		
	By:	 	 /s/ C. Ann Merrifield

	Name:	 	 C. Ann Merrifield

	Title:	 	 Chair of the Compensation Committee of the Board of Directors

	
	EXECUTIVE
	
	 /s/ Maria Palasis, Ph.D.

	Maria Palasis

  
 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00340-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00340-of-00352.parquet"}]]